Clinical Trials Directory

Trials / Recruiting

RecruitingNCT04365855

The Olmsted NAFLD Epidemiology Study (TONES)

Status
Recruiting
Phase
N/A
Study type
Interventional
Enrollment
800 (estimated)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Researchers are assessing the prevalence of Non-alcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH) in the population and assembling a well-characterized cohort of adults with NAFLD and NASH to validate models of NAFLD diagnosis and determine long-term outcomes.

Detailed description

Non-Alcoholic Fatty Liver Disease (NAFLD) is the most common cause of chronic liver disease in the world and a major public health issue in the US. Recent information on the prevalence of NAFLD in general and Non-Alcoholic Steatohepatitis (NASH) with fibrosis in particular is very scarce. Such information is crucial for defining the epidemiology of NAFLD, identifying risk factors for advanced fibrosis and longitudinal outcomes. This study will enroll a random sample of adults from Olmsted County, Minnesota, to validate machine learning models for NAFLD diagnosis and disease severity. These data would be fundamental for the development of screening strategies in the community, which are urgently needed for early diagnosis of liver fibrosis and therapeutic interventions before cirrhosis develops.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTMagnetic Resonance ElastographyCombines MRI imaging with sound waves to create a visual map (elastogram) showing the stiffness of body tissues.
OTHERBlood drawClinical blood tests with a focus on liver function parameters and diabetes
PROCEDURELiver biopsyIf indicated per MRE results a biopsy will be taken of the liver.
PROCEDUREFibro ScanIf indicated per MRE results a fibroscan will be performed of the liver.

Timeline

Start date
2020-10-10
Primary completion
2028-06-01
Completion
2028-06-01
First posted
2020-04-28
Last updated
2026-01-16

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT04365855. Inclusion in this directory is not an endorsement.